Sfoglia per Autore
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment
2022-05-14 Piermatteo, L; Scutari, R; Chirichiello, R; Alkhatib, M; Malagnino, V; Bertoli, A; Iapadre, N; Ciotti, M; Sarmati, L; Andreoni, M; Ceccherini-Silberstein, F; Salpini, R; Svicher, V
Impact of pre-existent drug resistance on virological efficacy of single tablet regimens in people living with HIV
2022-07-09 Stella, G; Volpicelli, L; Carlo, Dd; Vicenti, I; Celani, L; Maggiolo, F; Callegaro, Ap; Gennari, W; Francisci, D; Lombardi, F; Piermatteo, L; Bezenchek, A; Micheli, V; Rossetti, B; Santoro, M
Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure
2022-09-02 Salpini, R; D'Anna, S; Benedetti, L; Piermatteo, L; Gill, U; Svicher, V; Kennedy, Ptf
Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis
2022-12-01 Salpini, R; D'Anna, S; Piermatteo, L; Svicher, V
ULTRASENSITIVE HBV-RNA QUANTIFICATION AS A PROMISING BIOMARKER TO OPTIMIZE THE STAGING OF CHRONIC HBV INFECTION AND TO DETECT MINIMAL VIRAL ACTIVITY UNDER PROLONGED VIROLOGICAL SUPPRESSION AND OCCULT HBV INFECTION.
2023-01-01 Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini-Silberstein, F; Pietrangelo, A; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V; Salpini Oral presentation at the, R; Bari, M; 14-16 June, 2
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214
2023-01-01 Salpini, R; D’Anna, S; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, Am; Abate, Ml; Milella, M; Saracino, A; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher., V
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens
2023-01-01 Chenwi, Ca; Compagno, M; Benedetti, L; Duca, L; Matteucci, C; Ka'E, Ac; Piermatteo, L; Scutari, R; Khan, S; El Khalili, O; Ferrari, L; Malagnino, V; Teti, E; Bertoli, A; Salpini, R; Grelli, S; Iannetta, M; Sarmati, L; Andreoni, M; Ceccherini-Silberstein., F
Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort
2023-01-01 Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D’Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Battista Gaeta, G; Marchetti, G; Viale, P; Perno, C; Svicher, V; d’Arminio Monforte, A
Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression.
2023-01-01 Salpini, R; Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini Silberstein, F; Pietrangelo, A; Puoti, M; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V
Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response
2023-01-01 D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli
2023-01-01 Piermatteo, L; Salpini, R; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher, V
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir
2023-01-01 Salpini, R; D’Anna, S; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, A; Abate, M; Milella, M; Saracino, A; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Caviglia, G; Svicher, V
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing
2023-01-01 Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F
HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS
2023-01-01 Petrone, V; Scutari, R; Malagnino, V; Piermatteo, L; Compagno, M; Salpini, R; Teti, E; Iannetta, M; Minutolo, A; Santoro, Mm; Svicher, V; Andreoni, M; Balestrieri, E; Sarmati, L; Ceccherini-Silberstein, F; Grelli, S; Matteucci, C
PREVALENCE AND OUTCOME OF HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG PERSONS LIVING WITH HIV (PLWH) IN ITALY: THE DELTA-ICONA STUDY OC 150
2023-01-01 Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Gaeta, Gb; Marchetti, G; Rosselli Del Turco, E; Perno, Cf; Svicher, V; d'Arminio Monforte, A
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL
2023-01-01 R, S; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher., V
KINETICS OF THE THREE HBSAG ISOFORMS ALONG WITH HDV-RNA PREDICT VIROLOGICAL RESPONSE IN CHD PATIENTS TREATED WITH BULEVIRTIDE UP TO 96 WEEKS P 215
2023-01-01 D’Anna, ; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication
2023-01-01 Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage.
2023-01-01 Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R
Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks
2023-01-01 D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 14-mag-2022 | Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment | Piermatteo, L; Scutari, R; Chirichiello, R; Alkhatib, M; Malagnino, V; Bertoli, A; Iapadre, N; Ciotti, M; Sarmati, L; Andreoni, M; Ceccherini-Silberstein, F; Salpini, R; Svicher, V | Articolo su rivista | |
| 9-lug-2022 | Impact of pre-existent drug resistance on virological efficacy of single tablet regimens in people living with HIV | Stella, G; Volpicelli, L; Carlo, Dd; Vicenti, I; Celani, L; Maggiolo, F; Callegaro, Ap; Gennari, W; Francisci, D; Lombardi, F; Piermatteo, L; Bezenchek, A; Micheli, V; Rossetti, B; Santoro, M | Articolo su rivista | |
| 2-set-2022 | Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure | Salpini, R; D'Anna, S; Benedetti, L; Piermatteo, L; Gill, U; Svicher, V; Kennedy, Ptf | Articolo su rivista | |
| 1-dic-2022 | Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis | Salpini, R; D'Anna, S; Piermatteo, L; Svicher, V | Articolo su rivista | |
| 1-gen-2023 | ULTRASENSITIVE HBV-RNA QUANTIFICATION AS A PROMISING BIOMARKER TO OPTIMIZE THE STAGING OF CHRONIC HBV INFECTION AND TO DETECT MINIMAL VIRAL ACTIVITY UNDER PROLONGED VIROLOGICAL SUPPRESSION AND OCCULT HBV INFECTION. | Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini-Silberstein, F; Pietrangelo, A; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V; Salpini Oral presentation at the, R; Bari, M; 14-16 June, 2 | Intervento a convegno | |
| 1-gen-2023 | PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 | Salpini, R; D’Anna, S; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, Am; Abate, Ml; Milella, M; Saracino, A; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher., V | Intervento a convegno | |
| 1-gen-2023 | HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens | Chenwi, Ca; Compagno, M; Benedetti, L; Duca, L; Matteucci, C; Ka'E, Ac; Piermatteo, L; Scutari, R; Khan, S; El Khalili, O; Ferrari, L; Malagnino, V; Teti, E; Bertoli, A; Salpini, R; Grelli, S; Iannetta, M; Sarmati, L; Andreoni, M; Ceccherini-Silberstein., F | Intervento a convegno | |
| 1-gen-2023 | Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort | Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D’Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Battista Gaeta, G; Marchetti, G; Viale, P; Perno, C; Svicher, V; d’Arminio Monforte, A | Intervento a convegno | |
| 1-gen-2023 | Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression. | Salpini, R; Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini Silberstein, F; Pietrangelo, A; Puoti, M; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V | Intervento a convegno | |
| 1-gen-2023 | Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response | D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V | Intervento a convegno | |
| 1-gen-2023 | Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli | Piermatteo, L; Salpini, R; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher, V | Intervento a convegno | |
| 1-gen-2023 | The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir | Salpini, R; D’Anna, S; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, A; Abate, M; Milella, M; Saracino, A; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Caviglia, G; Svicher, V | Intervento a convegno | |
| 1-gen-2023 | Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing | Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-gen-2023 | HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS | Petrone, V; Scutari, R; Malagnino, V; Piermatteo, L; Compagno, M; Salpini, R; Teti, E; Iannetta, M; Minutolo, A; Santoro, Mm; Svicher, V; Andreoni, M; Balestrieri, E; Sarmati, L; Ceccherini-Silberstein, F; Grelli, S; Matteucci, C | Intervento a convegno | |
| 1-gen-2023 | PREVALENCE AND OUTCOME OF HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG PERSONS LIVING WITH HIV (PLWH) IN ITALY: THE DELTA-ICONA STUDY OC 150 | Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Gaeta, Gb; Marchetti, G; Rosselli Del Turco, E; Perno, Cf; Svicher, V; d'Arminio Monforte, A | Intervento a convegno | |
| 1-gen-2023 | HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL | R, S; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher., V | Intervento a convegno | |
| 1-gen-2023 | KINETICS OF THE THREE HBSAG ISOFORMS ALONG WITH HDV-RNA PREDICT VIROLOGICAL RESPONSE IN CHD PATIENTS TREATED WITH BULEVIRTIDE UP TO 96 WEEKS P 215 | D’Anna, ; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V | Intervento a convegno | |
| 1-gen-2023 | HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication | Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2023 | Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. | Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2023 | Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks | D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher, V | Intervento a convegno |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile